IPSEF Projected Dividend Yield
Ord/Ipsen SA ( OTCBB : IPSEF )Ipsen is global biotechnology specialty care company. Co. engages in research, development, manufacture and sale of pharmaceutical products for human healthcare. Co.'s product portfolio includes pharmaceutical products marketed around the world to specialists working in its targeted therapeutic areas (oncology, endocrinology, neurology and haematology). These products are specialist care drugs. Co. also markets products in other therapeutic areas including gastroenterology, cardiovascular and cognitive disorders. These products are primary care drugs. Co.'s brand names include Decapeptyl®, Somatuline®, Dysport®, Nutropin Aq®, Smecta®, Forlax®, Nisis®,Adrovance®, Exforge® and Adenuric®. 23 YEAR PERFORMANCE RESULTS |
IPSEF Dividend History Detail IPSEF Dividend News IPSEF Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend Amount (EUR) |
2020 |
N/A |
N/A |
Jun 04, 2020 |
Jun 05, 2020 |
1.0000 |
2020 Total: |
1.0000 |
||||
2019 |
N/A |
N/A |
Jun 03, 2019 |
Jun 04, 2019 |
1.0000 |
2019 Total: |
1.0000 |